DSM Capital Partners’s Celgene Corp CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
DSM Capital Partners's CELG Position: Q2 2017 in Review
DSM Capital Partners sold out of Celgene Corp (CELG) in Q2 2017, closing a stake of 1,411,816 shares — an estimated $176M sold.
DSM Capital Partners first reported a position in CELG in Q2 2013 and held it in 16 quarters. The position peaked at $561M in Q4 2014. 1,428 funds tracked by Wall St. Rank hold CELG as of Q2 2017.
- DSM Capital Partners reported no remaining Celgene Corp position as of Q2 2017 after selling out during the quarter.
- DSM Capital Partners sold 1,411,816 Celgene Corp shares in Q2 2017, an estimated $176M.
- DSM Capital Partners first reported a position in Celgene Corp in Q2 2013 and held it in 16 quarters.
- DSM Capital Partners's Celgene Corp position peaked at $561M in Q4 2014.
- 1,428 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2017.
Based on DSM Capital Partners's 13F filing for Q2 2017, filed 14 Aug 2017.